CCL22



CCL22

G1GG1P2PP2Y3YY3G4GG4A5AA5N6NN6V7VV7E8EE8D9DD9S10SS10I11II11C12CC12C13CC13Q14QQ14D15DD15Y16YY16I17II17R18RR18H19HH19P20PP20L21LL21P22PP22S23SS23R24RR24L25LL25V26VV26K27KK27E28EE28F29FF29F30FF30W31WW31T32TT32S33SS33K34KK34S35SS35C36CC36R37RR37K38KK38P39PP39G40GG40V41VV41V42VV42L43LL43I44II44T45TT45V46VV46K47KK47... and 21 more residue(s)...... and 21 more residue(s)

SMILES None
InChIKey None
Sequence GPYGANVEDSICCQDYIRHPLPSRLVKEFFWTSKSCRKPGVVLITVKNRDICADPRQVWVKKLLHKLS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL22

G1GG1P2PP2Y3YY3G4GG4A5AA5N6NN6V7VV7E8EE8D9DD9S10SS10I11II11C12CC12C13CC13Q14QQ14D15DD15Y16YY16I17II17R18RR18H19HH19P20PP20L21LL21P22PP22S23SS23R24RR24L25LL25V26VV26K27KK27E28EE28F29FF29F30FF30W31WW31T32TT32S33SS33K34KK34S35SS35C36CC36R37RR37K38KK38P39PP39G40GG40V41VV41V42VV42L43LL43I44II44T45TT45V46VV46K47KK47... and 21 more residue(s)...... and 21 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.